EBIT at other companies
Other financials
Where this comes from
Calculated from Janux Therapeutics’s reported figures.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Janux Therapeutics's EBIT?
- Janux Therapeutics (JANX) reported EBIT of -$34.21M in Q1 2026.
- How has Janux Therapeutics's EBIT changed year-over-year?
- Janux Therapeutics's EBIT increased by 2.0% year-over-year, from -$34.9M to -$34.21M.
- What is the long-term trend for Janux Therapeutics's EBIT?
- Over 4 years (2021 to 2025), Janux Therapeutics's EBIT has grown at a 47.9% compound annual growth rate (CAGR), from -$32.93M to -$157.67M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.